These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28656662)

  • 41. Temporal Trend in Androgen Status and Androgen-Sensitive Outcomes in Older Men.
    Hsu B; Cumming RG; Hirani V; Blyth FM; Naganathan V; Le Couteur DG; Seibel MJ; Waite LM; Handelsman DJ
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1836-46. PubMed ID: 26918290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone.
    Kuhn JM; Roca R; Laudat MH; Rieu M; Luton JP; Bricaire H
    Clin Endocrinol (Oxf); 1983 Oct; 19(4):513-20. PubMed ID: 6354523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The longitudinal relationship of sexual function and androgen status in older men: the Concord Health and Ageing in Men Project.
    Hsu B; Cumming RG; Blyth FM; Naganathan V; Le Couteur DG; Seibel MJ; Waite LM; Handelsman DJ
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1350-8. PubMed ID: 25629357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
    Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
    Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project.
    Travison TG; Nguyen AH; Naganathan V; Stanaway FF; Blyth FM; Cumming RG; Le Couteur DG; Sambrook PN; Handelsman DJ
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2464-74. PubMed ID: 21677041
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Higher Dihydrotestosterone Is Associated with the Incidence of Lung Cancer in Older Men.
    Chan YX; Alfonso H; Chubb SA; Handelsman DJ; Fegan PG; Hankey GJ; Golledge J; Flicker L; Yeap BB
    Horm Cancer; 2017 Apr; 8(2):119-126. PubMed ID: 28233278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relations Between Physical Activity, Subclinical Myocardial Injury, and Cardiovascular Mortality in the General Population.
    German C; Ahmad MI; Li Y; Soliman EZ
    Am J Cardiol; 2020 Jan; 125(2):205-209. PubMed ID: 31847957
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
    Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physical fitness matters more than physical activity in controlling cardiovascular disease risk factors.
    Sassen B; Cornelissen VA; Kiers H; Wittink H; Kok G; Vanhees L
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):677-83. PubMed ID: 19734792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The relationship between androgens concentrations (testosterone and dehydroepiandrosterone sulfate) and metabolic syndrome in non-obese elderly men].
    Rabijewski M; Papierska L; Kozakowski J; Zgliczyński W
    Endokrynol Pol; 2007; 58(6):496-504. PubMed ID: 18205106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of 10 days administration of percutaneous dihydrotestosterone on the pituitary-testicular axis in normal men.
    Kuhn JM; Rieu M; Laudat MH; Forest MG; Pugeat M; Bricaire H; Luton JP
    J Clin Endocrinol Metab; 1984 Feb; 58(2):231-5. PubMed ID: 6363434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma concentrations of pituitary and testicular hormones of fertile and infertile men.
    Stanwell-Smith R; Thompson SG; Haines AP; Jeffcoate SL; Hendry WF
    Clin Reprod Fertil; 1985 Mar; 3(1):37-48. PubMed ID: 3919915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low physical activity as a predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland.
    Barengo NC; Hu G; Lakka TA; Pekkarinen H; Nissinen A; Tuomilehto J
    Eur Heart J; 2004 Dec; 25(24):2204-11. PubMed ID: 15589637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men.
    Trifiro MD; Parsons JK; Palazzi-Churas K; Bergstrom J; Lakin C; Barrett-Connor E
    BJU Int; 2010 Jun; 105(11):1554-9. PubMed ID: 20002438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women.
    Naessen T; Sjogren U; Bergquist J; Larsson M; Lind L; Kushnir MM
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1889-97. PubMed ID: 20164295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ability of physical activity to predict cardiovascular disease beyond commonly evaluated cardiometabolic risk factors.
    McGuire KA; Janssen I; Ross R
    Am J Cardiol; 2009 Dec; 104(11):1522-6. PubMed ID: 19932786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
    van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia.
    Gann PH; Hennekens CH; Longcope C; Verhoek-Oftedahl W; Grodstein F; Stampfer MJ
    Prostate; 1995 Jan; 26(1):40-9. PubMed ID: 7531326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reproductive Hormones and Longitudinal Change in Bone Mineral Density and Incident Fracture Risk in Older Men: The Concord Health and Aging in Men Project.
    Hsu B; Cumming RG; Seibel MJ; Naganathan V; Blyth FM; Bleicher K; Dave A; Le Couteur DG; Waite LM; Handelsman DJ
    J Bone Miner Res; 2015 Sep; 30(9):1701-8. PubMed ID: 25736139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.